رجوع
39
نطاق اليوم
KWD 2.68
KWD 2.77
نطاق 52 أسبوعًا
KWD 2.68
KWD 4.50
حجم التداول
7,000
متوسط 50 يوم / 200 يوم
KWD 2.77
/
KWD 3.32
الإغلاق السابق
KWD 2.77
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (626 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 46.6 | 0.4 |
| P/B | 2.1 | 2.9 |
| ROE % | 4.5 | 3.7 |
| Net Margin % | 7.4 | 3.9 |
| Rev Growth 5Y % | 25.1 | 10.0 |
| D/E | 0.3 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 42.000
+1416.2%
مكرر الربحية المستقبلي
25.6
ربحية السهم المستقبلية
KWD 0.108
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
460 M
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2028 |
KWD 0.150
KWD 0.146 – KWD 0.155
|
550 M | 1 |
| FY2027 |
KWD 0.130
KWD 0.126 – KWD 0.134
|
500 M | 1 |
| FY2026 |
KWD 0.108
KWD 0.106 – KWD 0.112
|
460 M | 1 |
النقاط الرئيسية
Revenue grew 25.13% annually over 5 years — strong growth
Earnings grew 69.19% over the past year
ROE of 4.48% is below average
Debt/Equity of 0.34 — conservative balance sheet
Generating 90.60M in free cash flow
P/E of 46.55 — premium valuation
النمو
Revenue Growth (5Y)
25.13%
Revenue (1Y)13.39%
Earnings (1Y)69.19%
FCF Growth (3Y)N/A
الجودة
Return on Equity
4.48%
ROIC5.96%
Net Margin7.36%
Op. Margin17.53%
الأمان
Debt / Equity
0.34
Current Ratio1.95
Interest Coverage3.53
التقييم
P/E Ratio
46.55
P/B Ratio2.08
EV/EBITDA22.02
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 13.39% | Revenue Growth (3Y) | 13.19% |
| Earnings Growth (1Y) | 69.19% | Earnings Growth (3Y) | 78.35% |
| Revenue Growth (5Y) | 25.13% | Earnings Growth (5Y) | 47.65% |
| Profitability | |||
| Revenue (TTM) | 425.00M | Net Income (TTM) | 31.30M |
| ROE | 4.48% | ROA | 2.82% |
| Gross Margin | 68.89% | Operating Margin | 17.53% |
| Net Margin | 7.36% | Free Cash Flow (TTM) | 90.60M |
| ROIC | 5.96% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.34 | Current Ratio | 1.95 |
| Interest Coverage | 3.53 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 46.55 | P/B Ratio | 2.08 |
| P/S Ratio | 3.43 | PEG Ratio | 0.55 |
| EV/EBITDA | 22.02 | Dividend Yield | 0.00% |
| Market Cap | 1.46B | Enterprise Value | 1.64B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 425.00M | 374.80M | 331.73M | 281.31M | 173.35M |
| Net Income | 31.30M | 18.50M | 9.84M | -7.20M | 6.59M |
| EPS (Diluted) | 0.06 | 0.04 | 0.02 | -0.02 | 0.02 |
| Gross Profit | 292.80M | 258.30M | 229.43M | 193.99M | 122.85M |
| Operating Income | 74.51M | 49.20M | 41.27M | 39.36M | 21.60M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.11B | 1.11B | 973.68M | 923.56M | 640.72M |
| Total Liabilities | 401.00M | 403.30M | 446.97M | 442.06M | 282.08M |
| Shareholders' Equity | 698.90M | 699.90M | 526.37M | 481.81M | 357.41M |
| Total Debt | 238.70M | 233.60M | 313.80M | 220.96M | 180.37M |
| Cash & Equivalents | 55.00M | 64.80M | 37.50M | 42.19M | 55.11M |
| Current Assets | 213.50M | 222.70M | 158.94M | 206.69M | 131.47M |
| Current Liabilities | 109.40M | 109.90M | 74.89M | 166.26M | 72.69M |
درجات الاستراتيجيات
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#630 of 1024
النشاط الأخير
دخل
Cash Flow Compounder
Mar 24, 2026